CVS Health Corp.
$104.66+2.7%YTD+32.0%1Y+57.7%
Mentions · last 7 days
174
Price updated 1h ago·X counts updated 31m ago
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Healthcare Plans sits in its cycle right now — and what that implies for $CVS.
Medical - Healthcare Plans
Tech-enabled Medicare Advantage growth is bifurcating managed care — Oscar Health's AI-driven clinical platform is gaining member growth while the UNH Medicaid fraud litigation adds regulatory risk to legacy insurers. The healthcare plan up 90% this year signals the market is pricing AI-enhanced clinical cost management as a structural advantage.
Top industry ETF
$IHFiShares U.S. Healthcare Providers ETF
+13.4%YTD
+15.3%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
44.1How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
2.9%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
1.5%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
5.7%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
0.3Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
3.9%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
13.9%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
1.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q1 2026May 6, 2026$2.57$2.18+17.9%
Q4 2025Feb 10, 2026$1.09$1.00+9.0%
Q3 2025Oct 29, 2025$1.60$1.37+16.8%
Q2 2025Jul 31, 2025$1.81$1.46+24.0%
Next earningsThu, Jul 30·consensus EPS $1.86
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$100.4B+6.2%15.6%4.7%$2.31$3.4B
Q4 FY25$105.7B+8.2%12.8%2.0%$2.32$2.6B
Q3 FY25$102.9B+7.8%13.4%-3.1%$-3.13$98.0M
Q2 FY25$98.9B+8.4%13.7%2.4%$0.81$1.3B
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$408.5B$404.9B – $414.3B$7.42$7.33 – $7.6318
FY27$426.0B$416.4B – $439.9B$8.39$8.22 – $8.5518
FY28$449.3B$448.7B – $449.9B$9.65$9.03 – $10.1315
FY29$478.2B$470.0B – $494.1B$10.93$10.69 – $11.4111
FY30$498.7B$490.2B – $515.3B$12.20$11.93 – $12.737
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.9×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.97%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+13.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+26.3%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatMega float · 1.3B shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.6% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.495-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should KnowCVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?A Look at CVS Health Corp (CVS) After 3.0% Gain -- GF Value $77.69 vs Price $101.30Why CVS Stock Trounced the Market TodayWhy CVS Health (CVS) is a Top Momentum Stock for the Long-Term
More in Medical - Healthcare Plans
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · top 2 · last 7 days